<DOC>
	<DOCNO>NCT00771641</DOCNO>
	<brief_summary>RATIONALE : Patient abstract available PURPOSE : Patient abstract available</brief_summary>
	<brief_title>Fractionated Radiation Therapy Treating Advanced Squamous Cell Carcinoma Head Neck</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether hyperfractionation and/or accelerate fractionation ( split-course concomitant boost ) improve locoregional control rate standard fractionation radiotherapy patient advance squamous cell carcinoma head neck . II . Determine disease-free survival overall survival patient treat different radiotherapy fractionation scheme . III . Determine acute late toxicity fractionation schedule . IV . Compare quality life two regimen . OUTLINE : Randomized study . Arm I : Radiotherapy . Irradiation primary tumor involve at-risk nodal area use linear accelerator photon energy 1.25-6.0 MV ( dual energy arrangement may also use beam great 6.0 MV ) , electrons 4-25 MV , Co60 . Standard fractionation . Arm II : Radiotherapy . Targets equipment Arm I. Hyperfractionation . Arm III : Radiotherapy . Targets equipment Arm I . Accelerated split-course hyperfractionation . Arm IV : Radiotherapy . Targets equipment Arm I . Accelerated fractionation concomitant boost . PROJECTED ACCRUAL : A total 1,080 patient ( 270/arm ) accrue 5.75 year . If excessive toxicity note arm entry 324 634 patient , arm may close .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven squamous cell carcinoma head neck , include lymphoepithelioma anaplastic carcinoma Biopsy primary regional node acceptable No adenocarcinoma The following stage sit eligible : Stage III/IV oral cavity , include : Anterior 2/3 tongue Buccal mucosa Floor mouth Hard palate Gingiva Retromolar trigone Stage III/IV oropharynx , include : Tonsil pillar Faucial arch soft palate Posterolateral pharyngeal wall Stage II/III/IV base tongue hypopharynx Stage III/IV supraglottic larynx , include : Ventricular band Arytenoid Supra infrahyoid epiglottis Aryepiglottic fold ( tumor glottic subglottic site exclude ) Nonpalpable node detect CT MRI must least 1.0 cm diameter contain necrosis prove N+ disease No metastasis clavicle clinically radiologically PATIENT CHARACTERISTICS : Age : At least 18 Performance status : Karnofsky 60100 % Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Medically able withstand radiotherapy No second malignancy within 5 year except nonmelanomatous skin cancer Followup participate radiotherapist require PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy head neck No plan combined external beam interstitial boost irradiation Surgery : No prior surgery ( biopsy ) No plan combine pre postoperative program Radical neck dissection allow lymph node great 3 cm prior radiotherapy involvement persist treatment Resection persistent disease primary site may perform 6 week completion radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II lymphoepithelioma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>